MadaFacor
Well-known Member
Interesting development. I had assumed that the FDA would target the research chemical companies or their customers, given how prevalent the industry has become. Surprisingly, it seems that big pharma is taking the initial legal action against them taking civil action.
How do you anticipate this will impact the Chinese suppliers, if at all? Do you believe that the smaller research chemical firms, which aren't as visible or aggressive in their social media marketing as companies like Artic, will continue with their current practices?
Here's the link to the article for reference: https://www.reuters.com/legal/eli-lilly-sues-online-pharmacies-ban-us-imports-fake-mounjaro-2023-10-19/ (Eli Illy Sues)
I'm curious, does anyone have insights into the level of risk associated with purchasing and possessing research chemicals? Specifically, compounds like Tirz, Sema, BPC, Kissapeptin, and others?
How do you anticipate this will impact the Chinese suppliers, if at all? Do you believe that the smaller research chemical firms, which aren't as visible or aggressive in their social media marketing as companies like Artic, will continue with their current practices?
Here's the link to the article for reference: https://www.reuters.com/legal/eli-lilly-sues-online-pharmacies-ban-us-imports-fake-mounjaro-2023-10-19/ (Eli Illy Sues)
I'm curious, does anyone have insights into the level of risk associated with purchasing and possessing research chemicals? Specifically, compounds like Tirz, Sema, BPC, Kissapeptin, and others?